Webinar
Uncertainties With the Regulatory Environment for Continuous Manufacturing
August 12, 2020 | 11am ET / 8am PT | Thermo Fisher Scientific

Continuous manufacturing brings uncertainties with regulatory and adoption rates. Industry expert, Ajaz S. Hussain, PhD, will discuss these uncertainties and provide more insight into this innovation. Register now!

Webinar
Enabling high drug-loaded amorphous dispersion tablets
August 18, 2020 11 a.m. EST / 8 a.m. PST | Lonza Pharma & Biotech

Join us to gain an understanding of how to combine two different polymers, one “inside” and one “outside” the ASD to maximize performance, physical stability, and drug loading of ASD drug products. Register now.

Webinar
Powering Virtual Trials – In The Cloud
August 19, 2020 11 a.m. EST / 8 a.m. PST | Amazon Web Services

In this webinar you will hear from technology company uMotif on how they collaborate with pharma companies undertaking virtual and decentralized trials. Hear how new patient populations can be reached using cloud-based technology and learn what types of research data can be collected from different devices and wearables. Register now.

Webinar
Navigating CMC Regulatory Requirements for Accelerated Commercialization
August 25, 2020 | 11 a.m. EST / 8 a.m. PST | Lonza

Join us to discuss strategy, timing, process, practical and execution aspects to be considered in order to achieve a target  outcome. Case studies will be presented that demonstrate each of these challenges and the considerations necessary to meet fast-track timing requirements of clinical trials and registration applications. Register now.

Webinar
CROs: The Tip of the Spear in Maximizing the Value of Hybrid, Virtual, and Synthetic Clinical Trials
August 26, 2020 | 1pm EST / 10am PST | Rho

Hybrid, Virtual, and Synthetic trials are becoming part of a growing number of drug and biologics development programs. Join us as Rho experts discuss how to maximize the benefits of decentralized trials. Register now!

Webinar
From Respond to Reboot to Recover: Workforce health and safety are at the heart of resilient recovery
August 26, 2020 | 11 a.m. EST / 8 a.m. PST | Deloitte

Before businesses can recover, they will need to reboot, which will involve developing a holistic approach to managing new health risks, rethinking workforce safety, maximizing productivity, and furthering sales –while protecting and maintaining compliance with privacy and cybersecurity rights. Register now.

Webinar
Reducing barriers to patient care: A cross-industry collaboration
Thursday, August 27, 2020 | 1pm ET / 10am PT | Optum

Optum brings together cross-industry experts to share a case study detailing how an employer, provider, payer and pharmaceutical company worked together to address a hard-to-diagnose condition: migraine. Register now.

Webinar
Leveraging Innovative Technologies, Best Practices and Strategies to Accelerate Biologics Development and Commercialization
September 9, 2020 | 12pm ET / 9am PT | Thermo Fisher Scientific

This webinar will detail practical implementation of innovative technologies and solutions such as multi-attribute method, modernized cell line development workflow using high-yield cell lines and automated systems, next generation purification resins. It will also showcase best practices and strategies such as phase appropriate quality systems, and integrated drug substance – drug product solutions that leverage standardized technology platforms. Register now!

Webinar
Overcoming Scalability Challenges with Autologous Therapies
September 15, 2020 | 12pm ET / 9am PT | Catalent

Join experts Prof. Gerhard Bauer and Catalent’s Dr. James Crutchley as they discuss challenges and an innovative methodology to commercially scale autologous therapies. Register now.

Webinar
Wearable Technology for High-Frequency Cognitive and Mood Assessments in Depression
September 17, 2020 | 11am ET / 8am PT | Cambridge Cognition

The widespread adoption of smartphones and wearables makes monitoring symptoms in real time a credible option using brief measures designed for these devices – but is this acceptable and feasible for patients? This webinar will delve into the research findings of Takeda Pharmaceuticals, Cambridge Cognition, and CTRL Group, and share lessons learned adopting new technologies in clinical trials. Register now.

Webinar
USP Elastomer Chapter Revisions Will Become Official December 2020: What you Need to Know
September 17, 2020 11 a.m. EST / 8 a.m. PST | West Pharmaceutical Services, Inc.

This webinar will explain the baseline requirements for elastomeric physicochemical and functional properties.  Examples to illustrate qualification of components for intended applications will be included.  Register now.

Archives

Webinar
Metabolites in Safety Testing (MIST): Analytical Strategy
July 29, 2020 | 1pm EST / 10am PST | Frontage Laboratories

Regulatory agencies have provided recommendations on when and how to identify and characterize drug metabolites to ensure their non-clinical toxicity has been adequately evaluated. The studies conducted to comply with these recommendations are often referred to as metabolites in safety testing or MIST.

This presentation will review the origins of these recommendations and the specific requirements that need to be considered in designing studies to address the regulatory expectations. Register now.

Webinar
Patients can’t wait: Advancing Rare Disease & Oncology drug development during COVID-19
Recorded on: July 28, 2020 | Parexel

This virtual roundtable will explore the challenges and opportunities facing companies developing oncology and rare disease products during the COVID-19 pandemic. Parexel will be joined by Sara’s Cure, a Clear Cell Sarcoma patient advocacy group and charitable foundation. Register now to learn more.

Webinar
Challenges and Practical Solutions for Changing Over to Pre-filled Syringes for Parenteral Drugs
Recorded on July 22, 2020 | Thermo Fisher Scientific

It’s not uncommon for companies who launch commercial drug products in the pre-filled syringe format to do so after initially using other product formats such as vials for the development and clinical trial phases. Switch-overs need careful and strategic consideration because doing so requires investment in the new format but also offers critical patient benefits and improved stakeholder outcomes. During this webinar, you will learn more about benefits and risks of changing primary components during product development and how a design of experiments approach can be used to address issues and risks. Register now.

Webinar
Zero Deviation Mindset: Achieving Agility in Cell Therapy Supply Chains
Recorded on July 21, 2020 | Pluristem Therapeutics & ThermoFisher Scientific

Cell & gene therapy supply chains are inherently complex, requiring the utmost attention to quality, cold chain logistics, and chain of custody requirements. Join Thermo Fisher Scientific and Pluristem Therapeutics as we discuss lessons learned in developing the just-in-time supply chain for their phase III hip fracture study, and how these lessons are being used in their current efforts to treat severe COVID-19 cases complicated by Acute Respiratory Distress Syndrome (ARDS) in the United States. Register Now.

Webinar
BSEPcyte® and MDR3cyte®: Innovative Solutions for Investigating Drug-Induced Liver Injury
July 16, 2020 | 1pm EST / 10am PST | Frontage Laboratories

This presentation will benefit scientists wanting to learn more about DILI and/or those needing guidance on crucial transporter studies for better assessment of DDI potentials that is aligned with regulatory guidance. Register for our Webinar, featuring Kan He, on BSEPcyte® and MDR3cyte®: Innovative Solutions for Investigating Drug-Induced Liver Injury.

Webinar
EMD Serono & Aktana: Bringing Intelligent Engagement to Every Channel
Tuesday, July 14, 2020 | 2pm ET / 11am PT | Aktana

Join this webinar to hear Joel VanderMeulen, Senior Director, N&I Commercial Strategy and Operations at EMD Serono, and Derek Choy, Co-founder and President at Aktana, discuss:

  • Emerging market trends in the post-COVID world
  • How commercial teams can adapt to the “next normal” 
  • The three key components for successful omnichannel engagement

Register now.

Webinar
Becoming the early bird: Establishing a dialogue with the FDA around accelerating preclinical research
July 14, 2020 | 10 a.m. EST / 7 a.m. PST | Box

By establishing an early dialogue with the FDA—when potential products are still in preclinical testing—companies can gain valuable insights that could boost their chances of success. This webinar will bring together experts in preclinical trial design, R&D efficiency and regulatory affairs to offer advice on how companies can best engage the FDA early in the research process. Register now.

Webinar
De-risking the Development of Biotherapeutics Using Early Stage In Vitro Expression and Genetic Characterisation Tools
Recorded on: July 8, 2020 | Lonza

There is a high attrition rate during the development of biotherapeutics impacting the high cost of development. Early identification of the preferred expression host for manufacturing, along with lead candidate screening and material supply can help to reduce both attrition rates and cost.  Register for the webinar to learn more.

Webinar
What Real-World Data Is Telling Us About Managing Patients in a COVID-19 World
June 30, 2020 | 1:00pm ET | 10:00am PT | Optum

In this webinar, Optum will bring together their life sciences consultants, a large payer and pharmaceutical industry experts to share understanding about how patients are managing their medications — and how payers are managing patients — in the ever-changing COVID-19 world. Register now.

Webinar
Restore Elective Procedures in the new normal with Salesforce
Recorded on June 29, 2020 | Salesforce

We are in unprecedented times causing change and disruption like deferral of elective procedures and restricted access to HCPs. In this webinar, you will learn how MedTech companies are planning to rebound from COVID-19 by digitally re-engaging with physicians, HCPs, and health systems as elective procedure volume rebounds. Register now.

Webinar
State of Data Analytics and Machine Learning in the Life Sciences Industry: 2020 Benchmarking Survey
Recorded on June 25, 2020 | BHE

This webinar will present the results from BHE's industry survey with FiercePharma on how 100 of your peers are leveraging data analytics to respond to today’s challenges and generate timely, high value insights. The webinar will discuss how data analytics are being conducted across functional areas, how analytics approaches vary according to company size and type, which real-world data sources are most commonly leveraged, and more. Register now!

Webinar
Scalable protein expression with Pichia pastoris - optimising expression for the highest protein yield
June 25, 2020 10 a.m. EST / 7 a.m. PST | Lonza

In this webinar we will examine a number of the benefits of Lonza’s , XS® Pichia 2.0 including : speed, simple fermentation regimes, robust and scalable processes that can be tuned according to the specific objectives of a program, helping to advance new drug candidates through the development pipeline. We will examine the benefits of XS® Pichia 2.0 by referencing a number of case studies with different molecule formats. Register now.

Webinar
Virtual Series: Clinical Trials
June 22-24, 2020 | Free Virtual Event | FierceBiotech

FierceBiotech’s upcoming series will cover technology’s role in clinical trials. Panel discussions include: the use of sensors, wearables and other remote monitoring devices for tracking patient statistics, real-world data and patient-centric technology, and the role manufacturing plays in clinical trials. Register now.

Webinar
Fail Faster: How Biopharma Companies can Capitalize on Early Drug Development Failures
Recorded on June 19, 2020 | Research Solutions

This Fierce webinar will bring together executives with expertise in biopharma discovery, R&D and clinical trial design to discuss the benefits and challenges of the fail-fast strategy. It will include representatives of companies that have implemented such a strategy successfully and can provide advice on what did and did not work. Click here to register!

Webinar
Human Gut Microbiome-Based Contract Research Applications in Toxicology and Microbiome-Based Drug Discovery
Recorded on June 18, 2020 | Frontage Labs

Register for our Webinar, featuring David Kwok, on Human Gut Microbiome-Based Contract Research Applications in Toxicology and Microbiome-Based Drug Discovery. Save your spot & register today!

Webinar
Rapid and Data-Rich Chromatographic Method Development
Recorded on: June 17, 2020 | Cambrex

Rapid and systematic column and mobile phase screening has become an essential component of method development workflows at Cambrex Durham for NCE APIs and drug products. Utilizing the latest technologies in UPLC, a systematic approach to screening in method development can quickly provide more robust methods earlier in the clinical development lifecycle. Register now.

Webinar
Based on Exclusive Survey: Bioavailability Enhancement – Industry Insights, Key Challenges & Advanced Development Solutions
Recorded on June 16, 2020 | Catalent

Join this webcast as experts present the exclusive survey findings and introduce innovative scalable drug delivery technologies proven to address the industry’s growing need for improving solubility and enhancing bioavailability. Register now.

Webinar
Under Siege: Challenges and Mitigation Strategies for Clinical Trial Conduct During the COVID-19 Pandemic with Respect to Data Integrity
June 15, 2020 | 11am ET / 8am PT | Parexel

During the current COVID-19 pandemic, regulatory and compliance risk is an acute concern by health authorities, pharmaceutical manufacturers, medical practitioners and patients. This webinar will discuss the challenges and potential mitigation strategies, in accordance with appropriate application of regulations and COVID-19 guidance documents, to ensure GCP compliance with respect to managing lost to follow-up and missing data. Register now.

Webinar
Transforming medicine with expertise, flexibility and scale
Recorded on June 12, 2020 | Thermo Fisher Scientific

Join us for a webcast that will announce our progress on the 2020 investments to our Pharma Services business and provide focused insight on Thermo Fisher Scientific's expanding gene therapy capabilities. We will also cover an update on our strategy to ensure the delivery of drugs to customers and patients in lieu of the COVID-19 outbreak, as well as our evolving direct response to the virus through several ongoing projects. Register Now.

Webinar
Strategically Accelerate COVID-19 Diagnostics from Development to Market
June 11, 2020 | 1pm EST / 10am PST | Precision for Medicine

This webinar will explore real-world examples that will help you anticipate pitfalls, mitigate risk and accelerate development. Use the valuable insights we’ve gained from participation in multiple COVID-19 research studies to understand the contingencies for success and, just as critical, to anticipate pitfalls that can be avoided. Click here to save your spot!

Webinar
Transforming Clinical Development and Discovery with Multi-omic Data in the Era of Precision Medicine
June 9, 2020 11 a.m. EST / 8 a.m. PST | Acorn AI by Medidata, a Dassault Systèmes company

Join industry experts as they propose best practices for incorporating translational omic data in clinical development in order to yield novel insights and improve patient / study outcomes. Register now.

Webinar
How Technology Supports Patient Adherence to Specialty Medicines
Recorded on July 15, 2020 | InterSystems

RxMx’s Chameleon -- built on InterSystems IRIS for Health® -- features a configurable platform and a suite of apps to support the unique needs and challenges facing specialty medicines. Join this webinar to learn how the team has developed a variety of products to support solutions ranging from managing COVID-19 test data to keeping MS patients on track for scheduled infusions.

Webinar
Maximizing the Benefits of a Unified Clinical Data Capture and Management Platform
June 3, 2020 11 a.m. EST / 8 a.m. PST | Medidata

Register for the webinar to see how leveraging multiple solutions on a unified platform streamlines processes, drives operational efficiency, eliminates reconciliation, and provides faster data insights.

Webinar
Mastering the Virtual Clinical Trial
June 3, 2020 | 11:00am ET / 8:00am PT | CMIC Group

This Fierce webinar will bring together executives with expertise in R&D and technology implementation to explain the potential benefits of virtual clinical trials, as well as the ins and outs of designing and running them. It will include representatives from companies that have completed virtual clinical trials successfully and can provide advice on what did and did not work. Click here to save your spot today!

Webinar
Driving Quantitative Image Analysis for Early Phase Clinical Trials with Medidata and Medpace
June 2, 2020 | 10:00 am ET / 7:00 am PT | Medpace & Medidata

According to experts, quantitative image analysis can provide surrogate biomarkers in early phase clinical trials. In this webinar, experts discuss a seamless solution that facilitates data management and quantitative analysis of patient imaging data. Click here to register.

Webinar
Mitigating risks to ongoing clinical trials in the current COVID-19 environment
May 28, 2020 | 11am ET / 8am PT | Parexel

As companies strive to get new treatments to patients, it is now suddenly vital to mitigate new unexpected risks to ongoing clinical trials. Join Parexel’s experts as they share tips and best practices for mitigating these risks. Register today!

Webinar
Glass Delamination: Holistic approach for characterization and control
May 28, 2020 | 12pm ET / 9am PT | Stevanato Group

Drug stored in glass primary containers risk losing efficacy and safety when not properly tested for corrosion or delamination.  These phenomena occur when drug interacts with the inner glass surface over time causing glass matrix dissolution. In 2011, the FDA issued an industry warning leading to aggressive and extensive testing. Click here to register for this upcoming webinar.

Webinar
Understanding the Importance of Crystallization Processes to Avoid Unnecessary Cost, Risk and Development Delays
Recorded on: May 27, 2020 | Cambrex

A well-developed crystallization process can produce suitable particles that can facilitate consistent filtration, drying and formulation of the API and allow confident and reliable manufacturing of the final drug product, while avoiding unnecessary cost, risk and development delays. Register now.

Webinar
Optimizing Study Design: Addressing the Need for Real-Time Data for Emerging COVID-19 Therapies
May 21, 2020 | 11am ET / 8am PT | Parexel

The need for real-time data in a COVID-19 era.  Join Parexel experts during this live webinar as they analyze the role of Real-World Evidence (RWE) and how it supports the urgent need in emerging therapies for COVID-19. Register Now!

Webinar
In silico applications for in vitro drug discovery
Recorded On: May 20, 2020 | Crown Bioscience

Join Dr Sheng Guo to learn how to maximize your oncology in vitro datasets using in silico modeling. Find out how advanced data analysis is used to interrogate cell line and organoid genomics, novel combination regimens, and predictive biomarkers. Register here!

Webinar
Cardiac Safety London Online
May 20, 2020 | Time: 10am-3.30pm (BST) | Richmond Pharmacology Ltd

Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research. You will gain key insights to enable better patient outcomes, efficiency and cost effectiveness in global drug development. Register now.

Webinar
Covid 19 and Clinical Trials: Support Risk Mitigation and Recovery Plans With Data and Analytics
Recorded on: May 19, 2020 | Acorn AI

This webinar will address the impact of Covid 19 on clinical trials and highlight how industry-wide trial metrics and analytics can be used to support situation tracking, impact forecasting, and recovery planning. Register now.

Webinar
Impacts of Continuous Manufacturing in Development
Recorded On: May 13, 2020 | Thermo Fisher Scientific

Continuous manufacturing represents a new paradigm in the development and manufacturing of oral solid dose products. In a continuous manufacturing process, products are produced via an integrated series of modular unit operations. The raw materials are fed into the process and converted into the oral solid dose product at a continuous rate without interruption. As a result, this process has greater control, no scale up and can provide multiple benefits in both development and commercial manufacturing. Register Today!

Webinar
Implications of Historical Control Studies for Rare Disease Products
Recorded on May 13, 2020 | Rho

Development programs in rare diseases are becoming a major focus for small biotech and pharmaceutical companies. A crucial consideration is the choice of control group used to assess efficacy. Through recent case studies, we will discuss factors to consider, appropriate analysis, and the critical role that externally controlled studies play in supporting marketing applications for orphan/rare disease products. Register now.

Webinar
Coronavirus Virtual Series: Where are we now?
Virtual Event | Available On-Demand | FiercePharma and FierceHealthcare

The editorial teams of FiercePharma and FierceHealthcare bring you another week of live virtual updates and expert panels discussing the coronavirus. We’ll do a status update about our progress so far and what challenges remain ahead. Watch the sessions on-demand.

Webinar
Fast-start-up of vaccine studies for COVID-19: Tips and Considerations to do it Right
Recorded On: May 6, 2020 | Parexel

With the evolving situation of COVID-19 companies are rushing to get new vaccines to patients and bring this outbreak to a close. Join Parexel’s experts as they draw on vaccine experience and learnings to share tips and considerations for the fast start-up of vaccine trials. Save your spot today!

Webinar
Why MedTech Companies Should Have a Data Strategy for Value-Based Care
Wednesday, May 6, 2020 | 12pm ET / 9am PT | InterSystems

With the right data, analytic strategy, and program governance, forward-leaning companies can make an impact. Learn about Medtronic’s value-based healthcare strategy as a means to create benefits for providers, payers, and most importantly patients. Register now. ​​​​​​​

Webinar
Novel Trial Design Strategies with a Personalized ctDNA Assay
Recorded On: May 5, 2020 | Natera

Discover the latest advantages of using a personalized, tumor-informed circulating tumor DNA (ctDNA) test to design oncology clinical trials in solid tumors.  Learn how Signatera, a breakthrough technology, can be applied in early stage and late stage cancer trials, potentially enriching for patients most likely to respond to therapy, accelerating time to trial readout, or identifying early relapsers. Register to watch this recording!

Webinar
[Webinar] Model-Based Approach to Design Bispecific Modalities in Early Discovery
Applied BioMath

Learn how we used a tiered model-based approach of a bispecific antibody to appropriately cover multiple antigen pairs to help teams with informed antibody design, prioritization of experiments, and triaging of challenging antigen pairs. Watch the webinar on-demand.

Webinar
Coronavirus Virtual Series
Recorded on: March 30 - April 2, 2020 | FierceHealthcare and FiercePharma

FiercePharma and FierceHealthcare bring you a week of virtual updates and expert panels discussing the coronavirus. We're assembling a series of experts to discuss industry’s role in preparing for a pandemic and what steps can be taken to mitigate risk while dealing with the outbreak. Register for on-demand sessions now.

Webinar
[Webinar] Maintaining Momentum: Applying Recent Regulatory Guidance in the Midst of the Coronavirus
Recorded On: April 30, 2020 | Cato Research

A panel of CATO SMS experts will review the key issues contained in the emerging Agency Guidance and offer thoughts on what changes and options for sponsors may be seen in the coming months. Click here to register for this webinar.

Webinar
Declutter the Data in your Clinical Trial: Mitigate Risk Before it Becomes an Issue
Recorded on: April 29, 2020 | Medidata

Today more than ever the ability to process real-time data from disparate sources is critical to patient safety and data quality. Join us for a discussion and Q&A on how to find errors, trends, and anomalies in data to mitigate risk effectively.

Register Now >>>

Webinar
Successful Clinical Trials in the Era of Genetics-based Medicine
Recorded on: April 28, 2020 | InformedDNA

In this webinar, we'll explore how to address and overcome challenges in genetics-based clinical trials, using real-life case studies. InformedDNA is the authority on the appropriate use of genetic testing and the leading telemedicine provider of clinical genetics services. 

Who should attend? Anyone involved in designing or operating clinical trials for rare disease therapies. Register now.

Webinar
Parexel’s learnings from China: Clinical studies in a pandemic-transformed world
Recorded on: April 23, 2020 | Parexel

Join Parexel experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in China. Our panel will provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’ and what longer-term changes are likely to occur because of the pandemic – and the opportunities and challenges these changes present. Register Now.

Webinar
Getting Ahead of the Curve: Insights from COVID-19’s Frontlines
Recorded on: April 23, 2020 | InCrowd

How is COVID-19 impacting HCPs and patients? Join Daniel S. Fitzgerald, InCrowd CEO & President and Philip Moyer, InCrowd VP of Crowd Operations, to review the key findings. Register now.

Webinar
Leads Discovered: Accelerating Drug Discovery with Novel Tools for Structure & Sequence Activity Relationship Analysis
Recorded On: April 22, 2020 | PerkinElmer

As Biologics and sequence-based therapeutics become more pervasive, a new set of Sequence-Activity-Relationship tools are gaining importance in drug discovery. This webcast will showcase how AbbVie has been working with PerkinElmer solutions that extend their SAR analysis capabilities to include both small molecules and biologics in a single extensible platform that promises to expedite the lead discovery process. Click here to register.

Webinar
Performing end to end real-world evidence generation in the cloud with traceability and transparency- a Sanofi journey
Recorded on: April 21, 2020 | Amazon Web Services

In this webinar you will hear about Sanofi’s journey and experience in building an industrialized big data & analytics platform in the cloud that handles billions of rows of RWD data with complete data traceability, security, and supports both traditional (e.g comparative effectiveness) and advanced analytics (e.g. machine learning , NLP) for day to day evidence generation (RWE). Register now.

Webinar
Drug Product Advancement – A Path Through Development by Powder in Capsule Approach
Recorded on: April 14, 2020 | Lonza

Using micro-dosing technology and powder-in-capsule (PIC) or bottle (PIB) approaches, biopharmaceutical companies have the ability to increase speed to clinic, quickly assess their candidate compounds, and remain cost-conscious in early stage development.  Attendees working with an oral solid dosage development and manufacturing will benefit from this educational webinar.  This webinar will also be informative to attendees with responsibilities for rapid first-in-human studies with oral solid drug product. Register now.

Webinar
Clinical Trial Data meets the Real World: Bridging the Experimental and Post-Launch Worlds
Recorded on: April 2, 2020 | Acorn AI by Medidata

This webinar will address key considerations and best practices when combining clinical trial data with real world data to power big data analytics. Register now for the on-demand version.

Webinar
Before GLP: The Value of Robust Exploratory Toxicology Prior to Pivotal GLP Studies
Recorded on: March 26, 2020 | Frontage Laboratories

The webinar on March 26 is “Before GLP: The value of robust exploratory toxicology prior to pivotal GLP studies.”  Mr. Ryan will share experiences and stories, as well as suggestions for how to set up a successful IND approach.  We hope you will find our discussion insightful and help you avoid unexpected surprises in your IND-directed studies. Register to save your spot today!